| SC 13G/A | 2024-04-09 | JPMORGAN CHASE & CO | PMV Pharmaceuticals, Inc. | 15,573 | 0.0% | EDGAR |
| SC 13G/A | 2024-02-14 | Boxer Capital, LLC | PMV Pharmaceuticals, Inc. | 0 | 0.0% | EDGAR |
| SC 13G/A | 2024-02-14 | RTW INVESTMENTS, LP | PMV Pharmaceuticals, Inc. | 0 | 0.0% | EDGAR |
| SC 13G/A | 2024-02-14 | Avoro Capital Advisors LLC | PMV Pharmaceuticals, Inc. | 0 | 0.0% | EDGAR |
| SC 13G/A | 2024-02-14 | CITADEL ADVISORS LLC | PMV Pharmaceuticals, Inc. | - | 2.2% | EDGAR |
| SC 13G | 2024-02-14 | ArrowMark Colorado Holdings LLC | PMV Pharmaceuticals, Inc. | 2,714,143 | 5.3% | EDGAR |
| SC 13G/A | 2024-02-13 | VANGUARD GROUP INC | PMV Pharmaceuticals, Inc. | 2,405,307 | 4.7% | EDGAR |
| SC 13G/A | 2024-01-29 | BlackRock Inc. | PMV Pharmaceuticals, Inc. | 3,229,797 | 6.3% | EDGAR |
| SC 13G/A | 2024-01-23 | JPMORGAN CHASE & CO | PMV Pharmaceuticals, Inc. | 3,674,814 | 7.1% | EDGAR |
| SC 13G/A | 2024-01-23 | STATE STREET CORP | PMV Pharmaceuticals, Inc. | - | 1.4% | EDGAR |
| SC 13D/A | 2023-08-23 | ORBIMED ADVISORS LLC | PMV Pharmaceuticals, Inc. | 6,563,077 | 13.5% | EDGAR |
| SC 13G/A | 2023-07-07 | BlackRock Inc. | PMV Pharmaceuticals, Inc. | 4,677,028 | 10.2% | EDGAR |
| SC 13G | 2023-05-19 | CITADEL ADVISORS LLC | PMV Pharmaceuticals, Inc. | - | 3.3% | EDGAR |
| SC 13G/A | 2023-05-10 | STATE STREET CORP | PMV Pharmaceuticals, Inc. | - | 1.4% | EDGAR |
| SC 13G/A | 2023-02-14 | Boxer Capital, LLC | PMV Pharmaceuticals, Inc. | 3,163,795 | 6.9% | EDGAR |
| SC 13G/A | 2023-02-14 | Avoro Capital Advisors LLC | PMV Pharmaceuticals, Inc. | 3,060,000 | 6.7% | EDGAR |
| SC 13G/A | 2023-02-14 | RTW INVESTMENTS, LP | PMV Pharmaceuticals, Inc. | 4,356,920 | 9.5% | EDGAR |
| SC 13G/A | 2023-02-14 | CITADEL ADVISORS LLC | PMV Pharmaceuticals, Inc. | - | 2.0% | EDGAR |
| SC 13G/A | 2023-02-10 | STATE STREET CORP | PMV Pharmaceuticals, Inc. | - | 7.2% | EDGAR |
| SC 13G/A | 2023-02-10 | INTERWEST PARTNERS X LP | PMV Pharmaceuticals, Inc. | 1,614,911 | 3.5% | EDGAR |